News

Rossari Biotech Posts 4% Dip in Q1 Profit Despite Strong Revenue Growth

Mumbai, July 23, 2025  Specialty chemical manufacturer Rossari Biotech reported a 4% year-on-year decline in its Q1 FY26 net profit,… Read More

2 months ago

South Korea’s CoresteamChemo Partners with ATG Lifetech to Expand Global CRO Footprint

Seoul, South Korea  Two of South Korea’s leading biotech innovators, CoresteamChemo and ATG Lifetech, have announced a strategic partnership aimed… Read More

2 months ago

NKGen Biotech and HekaBio Forge Powerful Alliance to Launch Next-Gen NK Cell Therapy in Japan

Tokyo, Japan A transformative leap in Japan’s regenerative medicine landscape is underway as NKGen Biotech, a US-based clinical-stage biotech innovator,… Read More

2 months ago

Tulane University and 60 Degrees Pharmaceuticals Partner to Study New Lyme Disease Treatment

60 Degrees Pharmaceuticals, a company focused on developing medicines for infectious diseases, has entered a research partnership with Tulane University… Read More

2 months ago

10x Genomics and A*STAR Singapore Team Up to Revolutionize Cancer and Inflammatory Disease Research

10x Genomics, a leader in spatial biology and single-cell analysis, has joined forces with the Genome Institute of Singapore (A*STAR… Read More

2 months ago

Lisata and WARPNINE Complete First Stage of Promising Pancreatic Cancer Trial in Australia

Lisata Therapeutics and WARPNINE, a non-profit clinical research group in Western Australia, have announced the successful completion of patient enrollment… Read More

2 months ago

New Study Finds Key Marker That May Improve Pancreatic Cancer Treatment for Younger Patients

Sapu Biosciences, a subsidiary of GMP Biotechnology Limited, has partnered with Oncotelic Therapeutics to publish groundbreaking research that could change… Read More

2 months ago

ASAP and Allen Institute Join Forces to Unlock Insights Into Parkinson’s and Neurodegenerative Diseases

The Allen Institute and the Aligning Science Across Parkinson’s (ASAP) initiative have teamed up in a groundbreaking effort to advance… Read More

2 months ago

Amphix Bio Achieves Major Milestone with Orphan Drug Designation for AMFX-200 in Spinal Cord Injury Treatment

Amphix Bio, an emerging leader in regenerative medicine, has announced a significant breakthrough: the U.S. FDA has granted orphan drug… Read More

2 months ago

Innovent Biologics’ IBI343 Shines in Nature Medicine: A Major Step Forward in Gastric Cancer Treatment

Innovent Biologics, Inc., a leading biopharmaceutical company focused on developing and commercializing innovative therapies, has announced a significant milestone. The… Read More

2 months ago